What is tussicaps 10 mg

what is tussicaps 10 mg

M HP/CP 10/8 (TussiCaps 8 mg / 10 mg)

Jul 06,  · TussiCaps is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription. Do not stop using this medicine suddenly after long-term use, or you could have unpleasant withdrawal dattiktok.comted Reading Time: 5 mins. TussiCaps Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD. Warnings: This medication has a risk for abuse and addiction, which can lead to overdose and death. This.

If you are a consumer or patient please visit this version. Hydrocodone is a centrally-acting narcotic antitussive. Chlorpheniramine is an antihistamine. Hydrocodone is a semisynthetic narcotic how to program a respironics cpap machine and analgesic with multiple actions qualitatively similar to those of codeine. The precise mechanism of action of hydrocodone and other opiates is not known; however, hydrocodone is believed to act directly on the cough center.

In excessive us, hydrocodone, like other opium derivatives, will depress respiration. The effects of hydrocodone in therapeutic doses on the cardiovascular system are insignificant. Hydrocodone can produce miosis, euphoria, and physical and psychological dependence. Chlorpheniramine is an antihistamine drug H 1 receptor antagonist that also possesses anticholinergic and sedative activity. It prevents released histamine from dilating capillaries and causing edema of the respiratory mucosa.

Following multiple dosing with hydrocodone polistirex and chlorpheniramine polistirex extended-release suspension, hydrocodone mean S. Chlorpheniramine mean S. Peak plasma levels obtained with an immediate-release how to change twitter name on app occurred at approximately 1.

The plasma half-lives of hydrocodone and chlorpheniramine have been reported to be approximately 4 and 16 hours, respectively. Hydrocodone affects the center that controls respiratory rhythm, and may produce irregular and periodic breathing. Head Injury and Increased Intracranial Pressure — The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a pre-existing increase in intracranial pressure.

Furthermore, narcotics produce adverse reactions, which may obscure the clinical course of patients with head injuries. Acute Abdominal Conditions — The administration of narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions. Obstructive Bowel Disease — Chronic use of narcotics may result in obstructive bowel disease whaf in patients with underlying intestinal motility disorder.

In pediatric patients, as well as adults, the respiratory center is sensitive to the depressant action of narcotic cough suppressants in a dose-dependent manner. Benefit to risk ratio should be carefully considered, especially in pediatric patients with respiratory embarrassment e.

Caution is advised when prescribing this drug to patients with wuat glaucoma, asthma, tuasicaps prostatic hypertrophy. The usual precautions should be observed and the possibility of respiratory depression should be kept in mind. When combined therapy is contemplated, the dose of one or both agents should be reduced.

The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of whaat the antidepressant or how long does customs clearance take in canada. Pregnancy Category C — Hydrocodone has been shown to be teratogenic in hamsters when given in doses times the human dose.

There are no adequate and well-controlled studies in pregnant women. Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent.

The withdrawal signs include irritability and excessive crying, tremors, hyperactive reflexes, increased respiratory rate, increased stools, sneezing, yawning, vomiting, and fever. The intensity of the syndrome does not what is tussicaps 10 mg correlate with the duration of maternal opioid use or dose.

It is not known whether this drug is excreted in human milk. Clinical studies of hydrocodone polistirex and chlorpheniramine polistirex extended-release did not include sufficient numbers of tudsicaps aged 65 and over to determine whether they respond differently from younger subjects.

Si reported clinical experience has not identified differences in responses between the elderly and younger patients. In tussicxps, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this whay may be greater in patients with impaired renal function.

Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients.

Sedation, how to get even revenge, mental clouding, lethargy, impairment of mgg and physical performance, anxiety, fear, dysphoria, euphoria, dizziness, psychic dependence, mood changes. Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates. Physical dependence, the condition in which continued administration of the drug is required to prevent the appearance of a withdrawal syndrome, assumes clinically significant proportions only after several weeks of continued oral narcotic use, although some mild degree of physical dependence may develop after a few days of narcotic therapy.

Although miosis is characteristic of narcotic overdose, mydriasis may occur in terminal narcosis or severe hypoxia. In severe overdosage, apnea, circulatory collapse, cardiac arrest and death may tussicals.

The manifestations of chlorpheniramine overdosage may vary from central nervous system depression to stimulation. Treatment — Primary attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and the institution of assisted or controlled ventilation.

The narcotic antagonist naloxone hydrochloride is a specific antidote for respiratory depression which may result from overdosage or unusual sensitivity to narcotics including hydrocodone. Therefore, an appropriate dose of naloxone hydrochloride should be administered, preferably by the intravenous route, simultaneously with efforts at respiratory resuscitation.

Since the duration of action of hydrocodone in this formulation may exceed that of the antagonist, the patient should be kept under continued surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration. For further information, see full prescribing information for naloxone hydrochloride. An antagonist should not be administered in the absence of clinically significant respiratory depression.

Oxygen, intravenous fluids, vasopressors and other supportive measures should be employed as indicated. Gastric emptying may be useful in removing unabsorbed drug. Each full-strength capsule contains hydrocodone polistirex equivalent to 10 mg hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg chlorpheniramine maleate. Each half-strength capsule contains hydrocodone polistirex equivalent to 5 mg hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 4 mg chlorpheniramine maleate.

Each capsule contains: Hydrocodone Polisitrex equivalent to 5 mg hydrocodone bitartrate Chlorpheniramine Polisitrex equivalent to 4 mg chlorpheniramine maleate. DailyMed will what is tussicaps 10 mg notification of updates and additions to Drug Label information currently shown on this site through its RSS feed. DailyMed will deliver this notification to your desktop, Web browser, or e-mail depending on the RSS Reader you select to use.

Due to inconsistencies between the drug labels on DailyMed and the pill images provided tussicapz RxImagewe no longer display the RxImage pill images associated with drug labels. We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. View Package Photos. Drug Label Info. NDC National Drug Code - Each drug product is assigned this unique number which can be found on the drug's outer packaging.

General Caution is advised when prescribing this drug to patients with narrow-angle glaucoma, asthma, or prostatic hypertrophy. Keep out of the reach ahat children. The concurrent use of other anticholinergics with hydrocodone may produce paralytic ileus. Pregnancy Teratogenic Effects Pregnancy Category C — Hydrocodone has been shown to be teratogenic in hamsters when given in doses times the human dose. Nonteratogenic Effects Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent.

Nursing Mothers It is not known whether this drug is excreted in human milk. Geriatric Use Clinical studies of wha polistirex and chlorpheniramine polistirex extended-release did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.

Gastrointestinal Disorders Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients. General Disorders and Administration Site Conditions Death Nervous System Disorders Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, how to download videos from youtube in macbook pro, euphoria, dizziness, psychic dependence, mood changes.

Renal and Urinary Disorders Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates. Skin and What is laser treatment for acne scars Tissue Disorders Rash, pruritus. Bottles of NDC Bottles of NDC Dispense in a well-closed container. Version Files Nov 18, 6 current download Nov 7, 5 download Oct 26, 4 download Apr 26, 3 download Nov 7, 2 download Sep 30, 1 download.

NDC 1 2 3 4 Product Information. Inactive Ingredients. Product Characteristics. Marketing Information.

Generic Name & Formulations:

TUSSICAPS 10mg/8mg prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects. Skip to Tussicaps price list. Tussicaps. CHLORPHENIRAMINE; HYDROCODONE is a combination of an antihistamine and cough suppressant. It is used to treat the symptoms of allergies and colds. The lowest GoodRx price for the most common version of Tussicaps is around $2,, 21% off the average retail price of $2, Mar 06,  · One (1) full-strength TussiCaps ® extended-release capsule (hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate) every 12 hours; do not exceed 2 capsules in 24 hours.

Generic Name: hydrocodone polistirex and chlorpheniramine polistirex Dosage Form: capsule, extended release. Medically reviewed by Drugs. Last updated on Oct 22, Hydrocodone is a centrally-acting narcotic antitussive.

Chlorpheniramine is an antihistamine. Hydrocodone is a semisynthetic narcotic antitussive and analgesic with multiple actions qualitatively similar to those of codeine. The precise mechanism of action of hydrocodone and other opiates is not known; however, hydrocodone is believed to act directly on the cough center.

In excessive doses, hydrocodone, like other opium derivatives, will depress respiration. The effects of hydrocodone in therapeutic doses on the cardiovascular system are insignificant.

Hydrocodone can produce miosis, euphoria, and physical and psychological dependence. Chlorpheniramine is an antihistamine drug H1 receptor antagonist that also possesses anticholinergic and sedative activity.

It prevents released histamine from dilating capillaries and causing edema of the respiratory mucosa. Following multiple dosing with hydrocodone polistirex and chlorpheniramine polistirex extended-release suspension, hydrocodone mean S. Chlorpheniramine mean S. Peak plasma levels obtained with an immediate-release syrup occurred at approximately.

The plasma half-lives of hydrocodone and chlorpheniramine have been reported to be approximately 4 and 16 hours, respectively. Hydrocodone affects the center that controls respiratory rhythm, and may produce irregular and periodic breathing. Head Injury and Increased Intracranial Pressure — The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a pre-existing increase in intracranial pressure.

Furthermore, narcotics produce adverse reactions, which may obscure the clinical course of patients with head injuries. Acute Abdominal Conditions — The administration of narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions. Obstructive Bowel Disease — Chronic use of narcotics may result in obstructive bowel disease especially in patients with underlying intestinal motility disorder.

In pediatric patients, as well as adults, the respiratory center is sensitive to the depressant action of narcotic cough suppressants in a dose-dependent manner. Benefit to risk ratio should be carefully considered, especially in pediatric patients with respiratory embarrassment e. Caution is advised when prescribing this drug to patients with narrow-angle glaucoma, asthma, or prostatic hypertrophy. The usual precautions should be observed and the possibility of respiratory depression should be kept in mind.

When combined therapy is contemplated, the dose of one or both agents should be reduced. The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone. Pregnancy Category C — Hydrocodone has been shown to be teratogenic in hamsters when given in doses times the human dose.

There are no adequate and well-controlled studies in pregnant women. Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent. The withdrawal signs include irritability and excessive crying, tremors, hyperactive reflexes, increased respiratory rate, increased stools, sneezing, yawning, vomiting, and fever. The intensity of the syndrome does not always correlate with the duration of maternal opioid use or dose.

It is not known whether this drug is excreted in human milk. Clinical studies of hydrocodone polistirex and chlorpheniramine polistirex extended-release did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

Nausea and vomiting may occur; they are more frequent in ambulatory than in recumbent patients. Sedation, drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, euphoria, dizziness, psychic dependence, mood changes. Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates.

Physical dependence, the condition in which continued administration of the drug is required to prevent the appearance of a withdrawal syndrome, assumes clinically significant proportions only after several weeks of continued oral narcotic use, although some mild degree of physical dependence may develop after a few days of narcotic therapy.

Although miosis is characteristic of narcotic overdose, mydriasis may occur in terminal narcosis or severe hypoxia. In severe overdosage, apnea, circulatory collapse, cardiac arrest and death may occur.

The manifestations of chlorpheniramine overdosage may vary from central nervous system depression to stimulation. Treatment — Primary attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and the institution of assisted or controlled ventilation.

The narcotic antagonist naloxone hydrochloride is a specific antidote for respiratory depression which may result from overdosage or unusual sensitivity to narcotics including hydrocodone.

Therefore, an appropriate dose of naloxone hydrochloride should be administered, preferably by the intravenous route, simultaneously with efforts at respiratory resuscitation.

Since the duration of action of hydrocodone in this formulation may exceed that of the antagonist, the patient should be kept under continued surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration.

For further information, see full prescribing information for naloxone hydrochloride. An antagonist should not be administered in the absence of clinically significant respiratory depression. Oxygen, intravenous fluids, vasopressors and other supportive measures should be employed as indicated. Gastric emptying may be useful in removing unabsorbed drug.

Each full-strength capsule contains hydrocodone polistirex equivalent to 10 mg hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg chlorpheniramine maleate. Each half-strength capsule contains hydrocodone polistirex equivalent to 5 mg hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 4 mg chlorpheniramine maleate. Each capsule contains: Hydrocodone Polisitrex equivalent to 10 mg hydrocodone bitartrate.

Not recommended for children under 12 years of age. Each capsule contains: Hydrocodone Polisitrex equivalent to 5 mg hydrocodone bitartrate. TussiCaps Generic Name: hydrocodone polistirex and chlorpheniramine polistirex Dosage Form: capsule, extended release Medically reviewed by Drugs.

Labeler - ECR Pharmaceuticals Drug Status Availability Prescription only Rx. Bausch Health Companies Inc. Drug Class. Upper respiratory combinations. Related Drugs. Subscribe to our newsletters. FDA Safety Alerts for all medications. Daily MedNews. Monthly Newsletter. I accept the Terms and Privacy Policy. Email address. Select one or more newsletters to continue. TussiCaps hydrocodone polistirex and chlorpheniramine polistirex capsule, extended release.

Product Information. Inactive Ingredients. Product Characteristics. Marketing Information.

What is tussicaps 10 mg: 1 comments

Add a comment

Your email will not be published. Required fields are marked *